Axogen Receives $12.1 Million in Venture Capital Funding
ALACHUA, Fla.--(BUSINESS WIRE)--AxoGen, Inc., which is commercializing innovative peripheral nerve regeneration technologies, achieves another milestone by raising $12.1 million in Series C funding from Accuitive Medical Ventures, Cardinal Partners, De Novo Ventures and Springboard Capital II.